Arizona State Retirement System Ocugen, Inc. Transaction History

Arizona State Retirement System

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$1.11 - $1.87 $2,779 - $4,682	2,504 Added 4.27%	61,110 $79,000
Q3 2022 Nov 07, 2022	BUY	$1.75 - $3.1 $378 - $669	216 Added 0.37%	58,606 $104,000
Q2 2022 Jul 28, 2022	BUY	$1.83 - $3.45 $8,321 - $15,687	4,547 Added 8.44%	58,390 $133,000
Q1 2022 May 04, 2022	BUY	$2.34 - $4.72 $816 - $1,647	349 Added 0.65%	53,843 $178,000
Q4 2021 Feb 04, 2022	SELL	$4.38 - $15.67 $2,198 - $7,866	-502 Reduced 0.93%	53,494 $243,000
Q3 2021 Nov 12, 2021	BUY	$6.36 - $8.51 $18,240 - $24,406	2,868 Added 5.61%	53,996 $388,000
Q2 2021 Aug 02, 2021	BUY	$5.52 - $15.68 $282,226 - $801,687	51,128 New	51,128 $411,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.